Lombardi G - Search Results

1

Growth hormone-secreting tumor shrinkage after 3 months of octreotide-long-acting release therapy predicts the response at 12 months.

Colao A, Pivonello R, Auriemma RS, Galdiero M, Savastano S, Grasso LF, Lombardi G. Colao A, et al. Among authors: lombardi g. J Clin Endocrinol Metab. 2008 Sep;93(9):3436-42. doi: 10.1210/jc.2008-0424. Epub 2008 Jul 1. J Clin Endocrinol Metab. 2008. PMID: 18593770

2

The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study.

Colao A, di Somma C, Pivonello R, Cuocolo A, Spinelli L, Bonaduce D, Salvatore M, Lombardi G. Colao A, et al. Among authors: lombardi g. J Clin Endocrinol Metab. 2002 Mar;87(3):1088-93. doi: 10.1210/jcem.87.3.8336. J Clin Endocrinol Metab. 2002. PMID: 11889170

3

(99m)Technetium pentavalent dimercaptosuccinic acid scintigraphy in the follow-up of clinically nonfunctioning pituitary adenomas after radiotherapy.

Colao A, Ferone D, Lombardi G, Lastoria S. Colao A, et al. Among authors: lombardi g. Clin Endocrinol (Oxf). 2002 Jun;56(6):713-21. doi: 10.1046/j.1365-2265.2002.01537.x. Clin Endocrinol (Oxf). 2002. PMID: 12072040

4

Cardiovascular consequences of early-onset growth hormone excess.

Colao A, Spinelli L, Cuocolo A, Spiezia S, Pivonello R, di Somma C, Bonaduce D, Salvatore M, Lombardi G. Colao A, et al. Among authors: lombardi g. J Clin Endocrinol Metab. 2002 Jul;87(7):3097-104. doi: 10.1210/jcem.87.7.8573. J Clin Endocrinol Metab. 2002. PMID: 12107207

5

The cardiovascular risk of GH-deficient adolescents.

Colao A, Di Somma C, Salerno M, Spinelli L, Orio F, Lombardi G. Colao A, et al. Among authors: lombardi g. J Clin Endocrinol Metab. 2002 Aug;87(8):3650-5. doi: 10.1210/jcem.87.8.8777. J Clin Endocrinol Metab. 2002. PMID: 12161490

6

Effect of growth hormone (GH) and/or testosterone replacement on the prostate in GH-deficient adult patients.

Colao A, Di Somma C, Spiezia S, Filippella M, Pivonello R, Lombardi G. Colao A, et al. Among authors: lombardi g. J Clin Endocrinol Metab. 2003 Jan;88(1):88-94. doi: 10.1210/jc.2002-020812. J Clin Endocrinol Metab. 2003. PMID: 12519835

7

Twelve months of treatment with octreotide-LAR reduces joint thickness in acromegaly.

Colao A, Cannavò S, Marzullo P, Pivonello R, Squadrito S, Vallone G, Almoto B, Bichisao E, Trimarchi F, Lombardi G. Colao A, et al. Among authors: lombardi g. Eur J Endocrinol. 2003 Jan;148(1):31-8. doi: 10.1530/eje.0.1480031. Eur J Endocrinol. 2003. PMID: 12534355 Clinical Trial.

8

Reversal of acromegalic cardiomyopathy in young but not in middle-aged patients after 12 months of treatment with the depot long-acting somatostatin analogue octreotide.

Colao A, Marzullo P, Cuocolo A, Spinelli L, Pivonello R, Bonaduce D, Salvatore M, Lombardi G. Colao A, et al. Among authors: lombardi g. Clin Endocrinol (Oxf). 2003 Feb;58(2):169-76. doi: 10.1046/j.1365-2265.2003.01689.x. Clin Endocrinol (Oxf). 2003. PMID: 12580932

9

Somatostatin analogs in treatment of non-growth hormone-secreting pituitary adenomas.

Colao A, Filippella M, Di Somma C, Manzi S, Rota F, Pivonello R, Gaccione M, De Rosa M, Lombardi G. Colao A, et al. Among authors: lombardi g. Endocrine. 2003 Apr;20(3):279-83. doi: 10.1385/ENDO:20:3:279. Endocrine. 2003. PMID: 12721508 Review.

10

Acromegalic axial arthropathy: a clinical case-control study.

Scarpa R, De Brasi D, Pivonello R, Marzullo P, Manguso F, Sodano A, Oriente P, Lombardi G, Colao A. Scarpa R, et al. Among authors: lombardi g. J Clin Endocrinol Metab. 2004 Feb;89(2):598-603. doi: 10.1210/jc.2003-031283. J Clin Endocrinol Metab. 2004. PMID: 14764768

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,121 results

Search Page

Filters